BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31189050)

  • 1. Intravenous Iron and Maintenance Hemodialysis.
    Agarwal R
    N Engl J Med; 2019 Jun; 380(24):e46. PubMed ID: 31189050
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous Iron and Maintenance Hemodialysis.
    Afsar B; Elsurer Afsar R; Kanbay M
    N Engl J Med; 2019 Jun; 380(24):e46. PubMed ID: 31189053
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous Iron and Maintenance Hemodialysis.
    Nakanishi T; Kuragano T
    N Engl J Med; 2019 Jun; 380(24):e46. PubMed ID: 31189052
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous Iron and Maintenance Hemodialysis.
    Eisenga MF; Bakker SJL; Gaillard CAJM
    N Engl J Med; 2019 Jun; 380(24):e46. PubMed ID: 31189051
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous Iron and Maintenance Hemodialysis. Reply.
    Macdougall IC; Ford I
    N Engl J Med; 2019 Jun; 380(24):e46. PubMed ID: 31189054
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data.
    Pollak VE; Lorch JA; Shukla R; Satwah S
    BMC Nephrol; 2009 Feb; 10():6. PubMed ID: 19245700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenously administered iron on systemic blood pressure in hemodialysis patients.
    Ullian ME; Gadegbeku CA
    Nephron Clin Pract; 2004; 98(3):c83-6. PubMed ID: 15528942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron absorption and utilization in maintenance hemodialysis patients: oral and intravenous routes.
    Magana L; Dhar SK; Smith EC; Martinez C
    Mt Sinai J Med; 1984 Apr; 51(2):180-3. PubMed ID: 6610116
    [No Abstract]   [Full Text] [Related]  

  • 10. Beneficial effects of iron therapy in renal failure patients on hemodialysis.
    Fishbane S; Mittal SK; Maesaka JK
    Kidney Int Suppl; 1999 Mar; 69():S67-70. PubMed ID: 10084289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pivot Towards Moderating Intravenous Iron Therapy in Hemodialysis.
    Li X; Kshirsagar AV
    Am J Kidney Dis; 2019 Jul; 74(1):138-140. PubMed ID: 30910372
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical practice guidelines for maintaining adequate iron status with intravenous iron dextran in hemodialysis patients.
    Peacock E; Lindenfeld SM
    ANNA J; 1999 Jun; 26(3):337-43. PubMed ID: 10633605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of malnutrition and absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease and hemodialysis Algerian patients].
    Laras H; Haddoum F; Baghdali FY; Gagi N; Koceir EHA; Bitam A
    Nephrol Ther; 2022 Jul; 18(4):237-246. PubMed ID: 35644772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal trends in serum ferritin levels and associated factors in a national incident hemodialysis cohort.
    Kim T; Rhee CM; Streja E; Obi Y; Brunelli SM; Kovesdy CP; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2017 Feb; 32(2):370-377. PubMed ID: 28186572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens.
    Aronoff GR; Bennett WM; Blumenthal S; Charytan C; Pennell JP; Reed J; Rothstein M; Strom J; Wolfe A; Van Wyck D; Yee J;
    Kidney Int; 2004 Sep; 66(3):1193-8. PubMed ID: 15327417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance intravenous iron therapy in pediatric hemodialysis patients.
    Morgan HE; Gautam M; Geary DF
    Pediatr Nephrol; 2001 Oct; 16(10):779-83. PubMed ID: 11605781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When should iron supplementation in dialysis patients be avoided, minimized or withdrawn?
    Rostoker G
    Semin Dial; 2019 Jan; 32(1):22-29. PubMed ID: 29956370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.
    McCarthy JT; Regnier CE; Loebertmann CL; Bergstralh EJ
    Am J Nephrol; 2000; 20(6):455-62. PubMed ID: 11146312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
    Kotaki M; Uday K; Henriquez M; Blum S; Dave M
    Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
    [No Abstract]   [Full Text] [Related]  

  • 20. The Value of Intravenous Iron: Beyond the Cave of Speculation.
    Coyne DW; Fishbane S
    J Am Soc Nephrol; 2020 May; 31(5):896-897. PubMed ID: 32253272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.